Phio Pharmaceuticals Corp. (PHIO) NASDAQ
1.09
+0(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.09
+0(+0.00%)
Currency In USD
| Market Cap | 6.28M |
| Enterprise Value | -14.75M |
| P/E Ratio | -1.16 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.77 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.38 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.63 |
| Return On Equity | -0.77 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -9.22M |
| Net Income | -8.7M |
| Diluted EPS | -1.45 |
| Total Cash | 17.03M |
| Total Cash/Share | 1.47 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 66.93 |
| Book Value Per Share | 1.42 |
| 52-Week Change | -37.71 |
| 52-Week High | 4.19 |
| 52-Week Low | 0.81 |
| Moving Average 50 Days | 1.2 |
| Moving Average 200 Days | 1.49 |
| Average Volume | 258,287 |
| Shares Outstanding | 11.62M |
| % Held by Institutions | 4.22 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:9 |
| Last Split Date | July 05, 2024 |